Shopping Cart 0
Cart Subtotal
USD 0

Global Bio Similars/Subsequent Entry Biologic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4880

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 7320

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 9760

Details

Scope of the Report:

The global Bio Similars/Subsequent Entry Biologic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bio Similars/Subsequent Entry Biologic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Bio Similars/Subsequent Entry Biologic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bio Similars/Subsequent Entry Biologic market by product type and applications/end industries.

Market Segment by Companies, this report covers

Sun Pharma

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion Biocon

Hospira

Merck

Biogen idec

Genentech (Roche)

Pfizer

Celltrion

Biocon

Amgen

Samsung Biologics

Mylan

Dr. Reddy's Laboratories

Stada Arzneimittel AG

AbbVie

Sanofi-Aventis

Johnson & Johnson

Novo Nordisk

Eli Lilly

Novartis

3sbio

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Other

Market Segment by Applications, can be divided into

Tumor

Diabetes

Cardiovascular

Hemophilia

Other

READ MORE

Table Of Content

Scope

Table of Contents

1 Bio Similars/Subsequent Entry Biologic Market Overview

1.1 Product Overview and Scope of Bio Similars/Subsequent Entry Biologic

1.2 Classification of Bio Similars/Subsequent Entry Biologic by Types

1.2.1 Global Bio Similars/Subsequent Entry Biologic Revenue Comparison by Types (2019-2024)

1.2.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Types in 2018

1.2.3 Monoclonal Antibodies

1.2.4 Interferon

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Other

1.3 Global Bio Similars/Subsequent Entry Biologic Market by Application

1.3.1 Global Bio Similars/Subsequent Entry Biologic Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Global Bio Similars/Subsequent Entry Biologic Market by Regions

1.4.1 Global Bio Similars/Subsequent Entry Biologic Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.5 Global Market Size of Bio Similars/Subsequent Entry Biologic (2014-2024)

2 Manufacturers Profiles

2.1 Sun Pharma

2.1.1 Business Overview

2.1.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.2 Synthon Pharmaceuticals

2.2.1 Business Overview

2.2.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.3 Teva Pharmaceutical Industries

2.3.1 Business Overview

2.3.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.4 LG Life Sciences

2.4.1 Business Overview

2.4.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.5 Celltrion Biocon

2.5.1 Business Overview

2.5.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.6 Hospira

2.6.1 Business Overview

2.6.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.7 Merck

2.7.1 Business Overview

2.7.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.8 Biogen idec

2.8.1 Business Overview

2.8.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.9 Genentech (Roche)

2.9.1 Business Overview

2.9.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.10 Pfizer

2.10.1 Business Overview

2.10.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.11 Celltrion

2.11.1 Business Overview

2.11.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.12 Biocon

2.12.1 Business Overview

2.12.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.13 Amgen

2.13.1 Business Overview

2.13.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.14 Samsung Biologics

2.14.1 Business Overview

2.14.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.15 Mylan

2.15.1 Business Overview

2.15.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.16 Dr. Reddy's Laboratories

2.16.1 Business Overview

2.16.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.17 Stada Arzneimittel AG

2.17.1 Business Overview

2.17.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.18 AbbVie

2.18.1 Business Overview

2.18.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.19 Sanofi-Aventis

2.19.1 Business Overview

2.19.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.20 Johnson & Johnson

2.20.1 Business Overview

2.20.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.21 Novo Nordisk

2.21.1 Business Overview

2.2.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.22 Eli Lilly

2.22.1 Business Overview

2.22.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.23 Novartis

2.23.1 Business Overview

2.23.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.24 3sbio

2.24.1 Business Overview

2.24.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.24.2.1 Product A

2.24.2.2 Product B

2.24.3 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.25 Biotech

2.25.1 Business Overview

2.25.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.25.2.1 Product A

2.25.2.2 Product B

2.25.3 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.26 Gelgen

2.26.1 Business Overview

2.26.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.26.2.1 Product A

2.26.2.2 Product B

2.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.27 Innovent

2.27.1 Business Overview

2.27.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.27.2.1 Product A

2.27.2.2 Product B

2.27.3 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.28 Dong Bao

2.28.1 Business Overview

2.28.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.28.2.1 Product A

2.28.2.2 Product B

2.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.29 Ganlee

2.29.1 Business Overview

2.29.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.29.2.1 Product A

2.29.2.2 Product B

2.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

3 Global Bio Similars/Subsequent Entry Biologic Market Competition, by Players

3.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Bio Similars/Subsequent Entry Biologic Players Market Share

3.2.2 Top 10 Bio Similars/Subsequent Entry Biologic Players Market Share

3.3 Market Competition Trend

4 Global Bio Similars/Subsequent Entry Biologic Market Size by Regions

4.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Regions

4.2 North America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.3 Europe Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.5 South America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

5 North America Bio Similars/Subsequent Entry Biologic Revenue by Countries

5.1 North America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

5.2 USA Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

5.3 Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

5.4 Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6 Europe Bio Similars/Subsequent Entry Biologic Revenue by Countries

6.1 Europe Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

6.2 Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.3 UK Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.4 France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.5 Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.6 Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Countries

7.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

7.2 China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.3 Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.4 Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.5 India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

8 South America Bio Similars/Subsequent Entry Biologic Revenue by Countries

8.1 South America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

8.2 Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

8.3 Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

8.4 Colombia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Bio Similars/Subsequent Entry Biologic by Countries

9.1 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

9.2 Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.3 UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.4 Egypt Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.5 Nigeria Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.6 South Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

10 Global Bio Similars/Subsequent Entry Biologic Market Segment by Type

10.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Type (2014-2019)

10.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Type (2019-2024)

10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)

10.4 Interferon Revenue Growth Rate (2014-2024)

10.5 Erythropoietin Revenue Growth Rate (2014-2024)

10.6 Insulin Revenue Growth Rate (2014-2024)

10.7 Vaccines Revenue Growth Rate (2014-2024)

10.8 Other Revenue Growth Rate (2014-2024)

11 Global Bio Similars/Subsequent Entry Biologic Market Segment by Application

11.1 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2014-2019)

11.2 Bio Similars/Subsequent Entry Biologic Market Forecast by Application (2019-2024)

11.3 Tumor Revenue Growth (2014-2019)

11.4 Diabetes Revenue Growth (2014-2019)

11.5 Cardiovascular Revenue Growth (2014-2019)

11.6 Hemophilia Revenue Growth (2014-2019)

11.7 Other Revenue Growth (2014-2019)

12 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)

12.1 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)

12.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Regions (2019-2024)

12.3 North America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.4 Europe Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.6 South America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Bio Similars/Subsequent Entry Biologic Picture

Table Product Specifications of Bio Similars/Subsequent Entry Biologic

Table Global Bio Similars/Subsequent Entry Biologic and Revenue (Million USD) Market Split by Product Type

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Types in 2018

Figure Monoclonal Antibodies Picture

Figure Interferon Picture

Figure Erythropoietin Picture

Figure Insulin Picture

Figure Vaccines Picture

Figure Other Picture

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Application (2014-2024)

Figure Bio Similars/Subsequent Entry Biologic Revenue Market Share by Applications in 2018

Figure Tumor Picture

Figure Diabetes Picture

Figure Cardiovascular Picture

Figure Hemophilia Picture

Figure Other Picture

Table Global Market Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Table Sun Pharma Basic Information, Manufacturing Base and Competitors

Table Sun Pharma Bio Similars/Subsequent Entry Biologic Type and Applications

Table Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Type and Applications

Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Type and Applications

Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table LG Life Sciences Basic Information, Manufacturing Base and Competitors

Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Type and Applications

Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Celltrion Biocon Basic Information, Manufacturing Base and Competitors

Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Type and Applications

Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Hospira Basic Information, Manufacturing Base and Competitors

Table Hospira Bio Similars/Subsequent Entry Biologic Type and Applications

Table Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Bio Similars/Subsequent Entry Biologic Type and Applications

Table Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Biogen idec Basic Information, Manufacturing Base and Competitors

Table Biogen idec Bio Similars/Subsequent Entry Biologic Type and Applications

Table Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors

Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Type and Applications

Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Bio Similars/Subsequent Entry Biologic Type and Applications

Table Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Celltrion Basic Information, Manufacturing Base and Competitors

Table Celltrion Bio Similars/Subsequent Entry Biologic Type and Applications

Table Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Bio Similars/Subsequent Entry Biologic Type and Applications

Table Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Bio Similars/Subsequent Entry Biologic Type and Applications

Table Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Samsung Biologics Basic Information, Manufacturing Base and Competitors

Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Type and Applications

Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Bio Similars/Subsequent Entry Biologic Type and Applications

Table Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors

Table Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Type and Applications

Table Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors

Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Type and Applications

Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Bio Similars/Subsequent Entry Biologic Type and Applications

Table AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Type and Applications

Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Type and Applications

Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Type and Applications

Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Bio Similars/Subsequent Entry Biologic Type and Applications

Table Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Bio Similars/Subsequent Entry Biologic Type and Applications

Table Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table 3sbio Basic Information, Manufacturing Base and Competitors

Table 3sbio Bio Similars/Subsequent Entry Biologic Type and Applications

Table 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Biotech Basic Information, Manufacturing Base and Competitors

Table Biotech Bio Similars/Subsequent Entry Biologic Type and Applications

Table Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Gelgen Basic Information, Manufacturing Base and Competitors

Table Gelgen Bio Similars/Subsequent Entry Biologic Type and Applications

Table Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Innovent Basic Information, Manufacturing Base and Competitors

Table Innovent Bio Similars/Subsequent Entry Biologic Type and Applications

Table Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Dong Bao Basic Information, Manufacturing Base and Competitors

Table Dong Bao Bio Similars/Subsequent Entry Biologic Type and Applications

Table Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Ganlee Basic Information, Manufacturing Base and Competitors

Table Ganlee Bio Similars/Subsequent Entry Biologic Type and Applications

Table Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Players (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2017

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2018

Figure Global Top 5 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2018

Figure Global Top 10 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2018

Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Regions (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions in 2018

Figure North America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table North America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

Table North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure USA Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Europe Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure UK Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table South America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

Table South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Colombia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Egypt Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Nigeria Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure South Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Type (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type in 2018

Table Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Type (2019-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Type (2019-2024)

Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)

Figure Global Interferon Revenue Growth Rate (2014-2019)

Figure Global Erythropoietin Revenue Growth Rate (2014-2019)

Figure Global Insulin Revenue Growth Rate (2014-2019)

Figure Global Vaccines Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue by Application (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application in 2018

Table Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Application (2019-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Application (2019-2024)

Figure Global Tumor Revenue Growth Rate (2014-2019)

Figure Global Diabetes Revenue Growth Rate (2014-2019)

Figure Global Cardiovascular Revenue Growth Rate (2014-2019)

Figure Global Hemophilia Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Sun Pharma

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion Biocon

Hospira

Merck

Biogen idec

Genentech (Roche)

Pfizer

Celltrion

Biocon

Amgen

Samsung Biologics

Mylan

Dr. Reddy's Laboratories

Stada Arzneimittel AG

AbbVie

Sanofi-Aventis

Johnson & Johnson

Novo Nordisk

Eli Lilly

Novartis

3sbio

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

Company Profile

Company Profile Title

Scope of the Report:

The global Bio Similars/Subsequent Entry Biologic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bio Similars/Subsequent Entry Biologic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Bio Similars/Subsequent Entry Biologic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bio Similars/Subsequent Entry Biologic market by product type and applications/end industries.

Market Segment by Companies, this report covers

Sun Pharma

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion Biocon

Hospira

Merck

Biogen idec

Genentech (Roche)

Pfizer

Celltrion

Biocon

Amgen

Samsung Biologics

Mylan

Dr. Reddy's Laboratories

Stada Arzneimittel AG

AbbVie

Sanofi-Aventis

Johnson & Johnson

Novo Nordisk

Eli Lilly

Novartis

3sbio

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Other

Market Segment by Applications, can be divided into

Tumor

Diabetes

Cardiovascular

Hemophilia

Other

READ MORE

Scope

Table of Contents

1 Bio Similars/Subsequent Entry Biologic Market Overview

1.1 Product Overview and Scope of Bio Similars/Subsequent Entry Biologic

1.2 Classification of Bio Similars/Subsequent Entry Biologic by Types

1.2.1 Global Bio Similars/Subsequent Entry Biologic Revenue Comparison by Types (2019-2024)

1.2.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Types in 2018

1.2.3 Monoclonal Antibodies

1.2.4 Interferon

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Other

1.3 Global Bio Similars/Subsequent Entry Biologic Market by Application

1.3.1 Global Bio Similars/Subsequent Entry Biologic Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Global Bio Similars/Subsequent Entry Biologic Market by Regions

1.4.1 Global Bio Similars/Subsequent Entry Biologic Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)

1.5 Global Market Size of Bio Similars/Subsequent Entry Biologic (2014-2024)

2 Manufacturers Profiles

2.1 Sun Pharma

2.1.1 Business Overview

2.1.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.2 Synthon Pharmaceuticals

2.2.1 Business Overview

2.2.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.3 Teva Pharmaceutical Industries

2.3.1 Business Overview

2.3.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.4 LG Life Sciences

2.4.1 Business Overview

2.4.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.5 Celltrion Biocon

2.5.1 Business Overview

2.5.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.6 Hospira

2.6.1 Business Overview

2.6.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.7 Merck

2.7.1 Business Overview

2.7.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.8 Biogen idec

2.8.1 Business Overview

2.8.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.9 Genentech (Roche)

2.9.1 Business Overview

2.9.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.10 Pfizer

2.10.1 Business Overview

2.10.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.11 Celltrion

2.11.1 Business Overview

2.11.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.12 Biocon

2.12.1 Business Overview

2.12.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.13 Amgen

2.13.1 Business Overview

2.13.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.14 Samsung Biologics

2.14.1 Business Overview

2.14.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.15 Mylan

2.15.1 Business Overview

2.15.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.16 Dr. Reddy's Laboratories

2.16.1 Business Overview

2.16.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.17 Stada Arzneimittel AG

2.17.1 Business Overview

2.17.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.18 AbbVie

2.18.1 Business Overview

2.18.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.19 Sanofi-Aventis

2.19.1 Business Overview

2.19.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.20 Johnson & Johnson

2.20.1 Business Overview

2.20.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.21 Novo Nordisk

2.21.1 Business Overview

2.2.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.22 Eli Lilly

2.22.1 Business Overview

2.22.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.23 Novartis

2.23.1 Business Overview

2.23.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.24 3sbio

2.24.1 Business Overview

2.24.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.24.2.1 Product A

2.24.2.2 Product B

2.24.3 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.25 Biotech

2.25.1 Business Overview

2.25.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.25.2.1 Product A

2.25.2.2 Product B

2.25.3 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.26 Gelgen

2.26.1 Business Overview

2.26.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.26.2.1 Product A

2.26.2.2 Product B

2.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.27 Innovent

2.27.1 Business Overview

2.27.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.27.2.1 Product A

2.27.2.2 Product B

2.27.3 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.28 Dong Bao

2.28.1 Business Overview

2.28.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.28.2.1 Product A

2.28.2.2 Product B

2.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

2.29 Ganlee

2.29.1 Business Overview

2.29.2 Bio Similars/Subsequent Entry Biologic Type and Applications

2.29.2.1 Product A

2.29.2.2 Product B

2.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

3 Global Bio Similars/Subsequent Entry Biologic Market Competition, by Players

3.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Bio Similars/Subsequent Entry Biologic Players Market Share

3.2.2 Top 10 Bio Similars/Subsequent Entry Biologic Players Market Share

3.3 Market Competition Trend

4 Global Bio Similars/Subsequent Entry Biologic Market Size by Regions

4.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Regions

4.2 North America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.3 Europe Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.5 South America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

5 North America Bio Similars/Subsequent Entry Biologic Revenue by Countries

5.1 North America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

5.2 USA Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

5.3 Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

5.4 Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6 Europe Bio Similars/Subsequent Entry Biologic Revenue by Countries

6.1 Europe Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

6.2 Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.3 UK Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.4 France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.5 Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

6.6 Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Countries

7.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

7.2 China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.3 Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.4 Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.5 India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

8 South America Bio Similars/Subsequent Entry Biologic Revenue by Countries

8.1 South America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

8.2 Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

8.3 Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

8.4 Colombia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Bio Similars/Subsequent Entry Biologic by Countries

9.1 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

9.2 Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.3 UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.4 Egypt Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.5 Nigeria Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

9.6 South Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

10 Global Bio Similars/Subsequent Entry Biologic Market Segment by Type

10.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Type (2014-2019)

10.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Type (2019-2024)

10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)

10.4 Interferon Revenue Growth Rate (2014-2024)

10.5 Erythropoietin Revenue Growth Rate (2014-2024)

10.6 Insulin Revenue Growth Rate (2014-2024)

10.7 Vaccines Revenue Growth Rate (2014-2024)

10.8 Other Revenue Growth Rate (2014-2024)

11 Global Bio Similars/Subsequent Entry Biologic Market Segment by Application

11.1 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2014-2019)

11.2 Bio Similars/Subsequent Entry Biologic Market Forecast by Application (2019-2024)

11.3 Tumor Revenue Growth (2014-2019)

11.4 Diabetes Revenue Growth (2014-2019)

11.5 Cardiovascular Revenue Growth (2014-2019)

11.6 Hemophilia Revenue Growth (2014-2019)

11.7 Other Revenue Growth (2014-2019)

12 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)

12.1 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)

12.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Regions (2019-2024)

12.3 North America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.4 Europe Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.6 South America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Bio Similars/Subsequent Entry Biologic Picture

Table Product Specifications of Bio Similars/Subsequent Entry Biologic

Table Global Bio Similars/Subsequent Entry Biologic and Revenue (Million USD) Market Split by Product Type

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Types in 2018

Figure Monoclonal Antibodies Picture

Figure Interferon Picture

Figure Erythropoietin Picture

Figure Insulin Picture

Figure Vaccines Picture

Figure Other Picture

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Application (2014-2024)

Figure Bio Similars/Subsequent Entry Biologic Revenue Market Share by Applications in 2018

Figure Tumor Picture

Figure Diabetes Picture

Figure Cardiovascular Picture

Figure Hemophilia Picture

Figure Other Picture

Table Global Market Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)

Table Sun Pharma Basic Information, Manufacturing Base and Competitors

Table Sun Pharma Bio Similars/Subsequent Entry Biologic Type and Applications

Table Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Type and Applications

Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Type and Applications

Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table LG Life Sciences Basic Information, Manufacturing Base and Competitors

Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Type and Applications

Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Celltrion Biocon Basic Information, Manufacturing Base and Competitors

Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Type and Applications

Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Hospira Basic Information, Manufacturing Base and Competitors

Table Hospira Bio Similars/Subsequent Entry Biologic Type and Applications

Table Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Bio Similars/Subsequent Entry Biologic Type and Applications

Table Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Biogen idec Basic Information, Manufacturing Base and Competitors

Table Biogen idec Bio Similars/Subsequent Entry Biologic Type and Applications

Table Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors

Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Type and Applications

Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Bio Similars/Subsequent Entry Biologic Type and Applications

Table Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Celltrion Basic Information, Manufacturing Base and Competitors

Table Celltrion Bio Similars/Subsequent Entry Biologic Type and Applications

Table Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Bio Similars/Subsequent Entry Biologic Type and Applications

Table Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Bio Similars/Subsequent Entry Biologic Type and Applications

Table Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Samsung Biologics Basic Information, Manufacturing Base and Competitors

Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Type and Applications

Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Bio Similars/Subsequent Entry Biologic Type and Applications

Table Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors

Table Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Type and Applications

Table Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors

Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Type and Applications

Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Bio Similars/Subsequent Entry Biologic Type and Applications

Table AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Type and Applications

Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Type and Applications

Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Type and Applications

Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Bio Similars/Subsequent Entry Biologic Type and Applications

Table Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Bio Similars/Subsequent Entry Biologic Type and Applications

Table Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table 3sbio Basic Information, Manufacturing Base and Competitors

Table 3sbio Bio Similars/Subsequent Entry Biologic Type and Applications

Table 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Biotech Basic Information, Manufacturing Base and Competitors

Table Biotech Bio Similars/Subsequent Entry Biologic Type and Applications

Table Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Gelgen Basic Information, Manufacturing Base and Competitors

Table Gelgen Bio Similars/Subsequent Entry Biologic Type and Applications

Table Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Innovent Basic Information, Manufacturing Base and Competitors

Table Innovent Bio Similars/Subsequent Entry Biologic Type and Applications

Table Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Dong Bao Basic Information, Manufacturing Base and Competitors

Table Dong Bao Bio Similars/Subsequent Entry Biologic Type and Applications

Table Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Ganlee Basic Information, Manufacturing Base and Competitors

Table Ganlee Bio Similars/Subsequent Entry Biologic Type and Applications

Table Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Players (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2017

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2018

Figure Global Top 5 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2018

Figure Global Top 10 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2018

Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Regions (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions in 2018

Figure North America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table North America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

Table North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure USA Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Europe Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure UK Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table South America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)

Table South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Colombia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018

Figure Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Egypt Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure Nigeria Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Figure South Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Type (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type in 2018

Table Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Type (2019-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Type (2019-2024)

Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)

Figure Global Interferon Revenue Growth Rate (2014-2019)

Figure Global Erythropoietin Revenue Growth Rate (2014-2019)

Figure Global Insulin Revenue Growth Rate (2014-2019)

Figure Global Vaccines Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue by Application (2014-2019)

Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application in 2018

Table Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Application (2019-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Application (2019-2024)

Figure Global Tumor Revenue Growth Rate (2014-2019)

Figure Global Diabetes Revenue Growth Rate (2014-2019)

Figure Global Cardiovascular Revenue Growth Rate (2014-2019)

Figure Global Hemophilia Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Sun Pharma

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion Biocon

Hospira

Merck

Biogen idec

Genentech (Roche)

Pfizer

Celltrion

Biocon

Amgen

Samsung Biologics

Mylan

Dr. Reddy's Laboratories

Stada Arzneimittel AG

AbbVie

Sanofi-Aventis

Johnson & Johnson

Novo Nordisk

Eli Lilly

Novartis

3sbio

Biotech

Gelgen

Innovent

Dong Bao

Ganlee